SkyView Investment Advisors’s Coeptis Therapeutics Warrants COEPW Stock Holding History

SkyView Investment Advisors’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1K	Sell	50,122 -5,000	-9%	-$60	﹤0.01%	299
2025 Q4	$1K	Hold	55,122	–	–	﹤0.01%	325
2025 Q3	$1K	Hold	55,122	–	–	﹤0.01%	316
2025 Q2	$1K	Hold	55,122	–	–	﹤0.01%	317
2025 Q1	$1K	Hold	55,122	–	–	﹤0.01%	309
2024 Q4	$1K	Hold	55,122	–	–	﹤0.01%	278
2024 Q3	$1K	Hold	55,122	–	–	﹤0.01%	292
2024 Q2	$1K	Hold	55,122	–	–	﹤0.01%	338
2024 Q1	$1K	Hold	55,122	–	–	﹤0.01%	323
2023 Q4	$2K	Hold	55,122	–	–	﹤0.01%	121
2023 Q3	$1K	Hold	55,122	–	–	﹤0.01%	517
2023 Q2	$4K	Hold	55,122	–	–	﹤0.01%	511
2023 Q1	$8K	Hold	55,122	–	–	﹤0.01%	463
2022 Q4	$6K	Hold	55,122	–	–	﹤0.01%	433
2022 Q3	$2K	Buy	55,122 +35,070	+175%	+$1.68K	﹤0.01%	514
2022 Q2	$1K	Buy	+20,052	New	+$1.51K	﹤0.01%	567

Other funds holding COEPW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HHGC

Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SkyView Investment Advisors's COEPW Position: Q1 2026 in Review

SkyView Investment Advisors reduced its Coeptis Therapeutics Warrants (COEPW) stake by 9.1% in Q1 2026, selling an estimated $60 and leaving 50,122 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #299.

SkyView Investment Advisors first reported a position in COEPW in Q2 2022 and has held it in 16 quarters since. The position peaked at $8K in Q1 2023. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

SkyView Investment Advisors held 50,122 shares of Coeptis Therapeutics Warrants worth $1K as of Q1 2026.
SkyView Investment Advisors sold 5,000 Coeptis Therapeutics Warrants shares in Q1 2026, an estimated $60.
Coeptis Therapeutics Warrants made up ﹤0.01% of SkyView Investment Advisors's portfolio in Q1 2026, its #299 holding.
SkyView Investment Advisors first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and has held it in 16 quarters since.
SkyView Investment Advisors's Coeptis Therapeutics Warrants position peaked at $8K in Q1 2023.
10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.